journal article·2026-12-31Open access

Antibacterial and antibiofilm evaluation of biogenic ternary CuO–AgO–MgO nanocomposite against clinical isolates of carbapenem-resistant Klebsiella pneumoniae

Mohammed S. Abdulrahman, Nasir A. Ibrahim, Fathy M. Elkady, Amr H. Hashem, Faisal Alsenani, Nosiba S. Basher, Faisal H. Altemani, Abdel-Aty E. Alfeky, Ayman Salama, Adnan Alharbi, Sulaiman A. Alsalamah, Fahd A. Nasr, Mohammed Aufy, Ebrahim Saied

Abstract

Escalation of antimicrobial resistance amongst Klebsiella pneumoniae (K. pneumoniae) represents a remarkable worldwide health concern. This study reports the green biosynthesis of copper, silver and magnesium oxide trimetallic nanocomposites (CuO–AgO–MgO TNCs) using banana peel extract as a safe and sustainable reducing and stabilizing agent and emphasizes its inhibitory activity against carbapenem-resistant K. pneumoniae (CRKP) strains. The TNCs were characterized by ultraviolet–visible (UV–vis) spectroscopy, Fourier transform infra-red (FTIR) spectroscopy, X-ray diffraction (XRD) analysis, transmission electron microscope (TEM), scanning electron microscopy (SEM) and energy-dispersive X-ray (EDX) analysis, confirming their crystalline structure (average size 125 nm) and elemental composition (Cu, Ag, Mg, O). Cytotoxicity assessment using WI-38 normal cells showed minimal toxic effect with an IC50 of 193.49 ± 2.85 µg/mL. Antibacterial activity was evaluated against genotypically diverse CRKP strains. Well diffusion assay (WDA) showed inhibition zones of 18–38 mm, while the broth microdilution assay provided minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values ranging from 8 to 1024 µg/mL and 128 to 2048 µg/mL, respectively. Time-kill assays indicated rapid bacterial growth reduction within 2 h, and antibiofilm assays showed 25–91% inhibition of biofilm formation. The image provided by SEM revealed pronounced morphological alterations in treated bacterial cells. Our findings exhibited biogenic CuO–AgO–MgO TNCs with potent antibacterial and antibiofilm activities against CRKP while showing negligible toxicity towards normal cells, highlighting their potential as a safe and effective alternative antimicrobial strategy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Copper-based nanomaterials and applications · Nanoparticles: synthesis and applications · Magnesium Oxide Properties and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Microbiology and Immunology Department, Faculty of Pharmacy (Boys), Al-Azhar University

Department of Microbiology and Immunology, Faculty of Pharmacy, Menoufia National University

Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU)

Botany and Microbiology Department, Faculty of Science, Al-Azhar University

Department of Pharmaceutical Sciences, College of Pharmacy, Umm Al-Qura University

Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk

Department of Pharmaceutics, Faculty of Pharmacy, University of Tabuk

Pharmaceutical Practices Department, College of Pharmacy, Umm Al-Qura University

Department of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, University of Vienna

Funding

the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University

References (100+)

Show source-provided references
1. 10.1093/jac/dkae18410.1093/jac/dkae184 ↗
2. Maxwell SY. Investigation and management of Klebsiella pneumoniae outbreak in intensive care unit of Tanta University Emergency Hospital. Egypt J Med Microbiol. 2021;30(3):53–58.10.51429/EJMM30307 ↗
3. 10.3389/fmicb.2021.75066210.3389/fmicb.2021.750662 ↗
4. Mohamed AA, Saed S, El-Sayed SR, et al. A combined therapy of meropenem–ZnO nanoparticles efficiently eliminates carbapenem-resistant Klebsiella pneumoniae biofilms, with reduced nephrotoxicity (in vitro). Lett Appl Microbiol. 2024;77(12):ovae136.10.1093/lambio/ovae136 ↗
5. 10.3855/jidc.1299610.3855/jidc.12996 ↗
6. Vásquez-Ponce F, Vianello M, Becerra J, et al. Global epidemiological trend of Klebsiella pneumoniae ST340: emergence of subclade KL15 co-producing K pneumoniae carbapenemase-2 and New Delhi metallo-β-lactamase-7 in the Americas. Lancet Microbe. 2025;6(2):100990.10.1016/j.lanmic.2024.100990 ↗
7. 10.1093/ofid/ofad64910.1093/ofid/ofad649 ↗
8. Wu Y, Jiang T, He X, et al. Global phylogeography and genomic epidemiology of carbapenem-resistant blaOXA-232-carrying Klebsiella pneumoniae sequence type 15 lineage. Emerg Infect Dis. 2023;29(11):2246–2256.
9. 10.3390/antibiotics1104043110.3390/antibiotics11040431 ↗
10. Ranjbar R, Karami A, Farshad S, et al. Typing methods used in the molecular epidemiology of microbial pathogens: a how-to guide. New Microbiol. 2014;37(1):1–15.
11. 10.1186/s13568-021-01282-w10.1186/s13568-021-01282-w ↗
12. 10.1155/2020/889472710.1155/2020/8894727 ↗
13. 10.3390/biomedicines1102041310.3390/biomedicines11020413 ↗
14. 10.1016/j.nantod.2019.10076710.1016/j.nantod.2019.100767 ↗
15. 10.1021/acs.chemrev.1c0049310.1021/acs.chemrev.1c00493 ↗
16. 10.3390/ma1301000110.3390/ma13010001 ↗
17. 10.3390/catal1305089110.3390/catal13050891 ↗
18. 10.1016/j.jclepro.2024.14345410.1016/j.jclepro.2024.143454 ↗
19. 10.1016/j.jclepro.2021.12919810.1016/j.jclepro.2021.129198 ↗
20. 10.1515/revce-2017-000510.1515/revce-2017-0005 ↗
21. 10.1016/j.talo.2021.10008010.1016/j.talo.2021.100080 ↗
22. 10.3390/biom1201003110.3390/biom12010031 ↗
23. Szerencsés B, Igaz N, Tóbiás Á, et al. Size-dependent activity of silver nanoparticles on the morphological switch and biofilm formation of opportunistic pathogenic yeasts. BMC Microbiol. 2020;20:1–13.10.1186/s12866-020-01858-9 ↗
24. 10.1016/j.pnsc.2013.02.00110.1016/j.pnsc.2013.02.001 ↗
25. Sachin S, Muthuvel V, Bosco Franklin J. Plant-mediated synthesis of metal oxide (CuO&MgO) nanocomposites for the suppression of drug-resistant pathogens. Waste Biomass Valor. 2025;16(4):1627–1641.10.1007/s12649-024-02722-x ↗
26. 10.3389/fchem.2023.114361410.3389/fchem.2023.1143614 ↗
27. 10.1038/s41598-024-83199-510.1038/s41598-024-83199-5 ↗
28. 10.3390/life1411140810.3390/life14111408 ↗
29. 10.3389/fmicb.2022.83177010.3389/fmicb.2022.831770 ↗
30. White TJ Bruns T Lee S et al. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. Vol. 18; 1990. p. 315–322.10.1016/B978-0-12-372180-8.50042-1 ↗
31. 10.3390/microorganisms1002044910.3390/microorganisms10020449 ↗
32. 10.61186/mlj.17.1.1310.61186/mlj.17.1.13 ↗
33. 10.1007/s00284-020-02199-610.1007/s00284-020-02199-6 ↗
34. 10.1007/s13205-021-02765-010.1007/s13205-021-02765-0 ↗
35. 10.3390/medicina5809124510.3390/medicina58091245 ↗
36. 10.3389/fcimb.2021.79230510.3389/fcimb.2021.792305 ↗
37. 10.1016/j.foohum.2023.09.02410.1016/j.foohum.2023.09.024 ↗
38. 10.1016/j.inoche.2021.10892310.1016/j.inoche.2021.108923 ↗
39. 10.1016/j.msec.2018.06.07010.1016/j.msec.2018.06.070 ↗
40. 10.3390/jof705037210.3390/jof7050372 ↗
41. 10.1166/jnn.2018.1545810.1166/jnn.2018.15458 ↗
42. 10.1016/0022-1759(94)90034-510.1016/0022-1759(94)90034-5 ↗
43. Alley MC, Scudiero DA, Monks A, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988;48(3):589–601.
44. 10.1016/0006-3002(63)90513-410.1016/0006-3002(63)90513-4 ↗
45. 10.1186/s12302-022-00684-210.1186/s12302-022-00684-2 ↗
46. 10.3389/fmicb.2024.145462310.3389/fmicb.2024.1454623 ↗
47. Kamaraj C Naveenkumar S Prem P et al. Green synthesis: an eco-friendly route for the synthesis of silver and palladium nanoparticles using Laureliopsis philippiana and their toxicity in mosquitoes and zebrafish larvae; 2023 Available at SSRN 4481291.10.2139/ssrn.4481291 ↗
48. CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Clinical and Laboratory Standards Institute; 2024.
49. 10.1038/s41598-024-54702-910.1038/s41598-024-54702-9 ↗
50. 10.2147/IJN.S49749410.2147/IJN.S497494 ↗
51. 10.1039/d4na00142g10.1039/d4na00142g ↗
52. 10.1016/j.jpha.2015.11.00510.1016/j.jpha.2015.11.005 ↗
53. 10.1186/s12866-024-03228-110.1186/s12866-024-03228-1 ↗
54. 10.3389/fcimb.2021.74873910.3389/fcimb.2021.748739 ↗
55. 10.1016/j.jiph.2020.12.00110.1016/j.jiph.2020.12.001 ↗
56. 10.2147/IDR.S24406410.2147/IDR.S244064 ↗
57. 10.1038/s41429-018-0126-z10.1038/s41429-018-0126-z ↗
58. 10.1039/d1nr08144f10.1039/d1nr08144f ↗
59. 10.3390/ma1106094010.3390/ma11060940 ↗
60. 10.3390/nano1219331210.3390/nano12193312 ↗
61. 10.1016/j.mseb.2024.11768110.1016/j.mseb.2024.117681 ↗
62. 10.1016/j.molliq.2019.11097510.1016/j.molliq.2019.110975 ↗
63. Hussein S, Mahmoud AM, Elgebaly H, et al. Green synthesis of trimetallic nanocomposite (Ru/Ag/Pd)‐Np and its in vitro antimicrobial and anticancer activities. J Chem. 2022;2022(1):1–14.10.1155/2022/4593086 ↗
64. 10.1016/j.jece.2018.02.03810.1016/j.jece.2018.02.038 ↗
65. 10.3390/microorganisms1106138010.3390/microorganisms11061380 ↗
66. 10.3390/catal1010113810.3390/catal10101138 ↗
67. 10.46481/jnsps.2021.23710.46481/jnsps.2021.237 ↗
68. Rusli NS, Embong Z, Hashim NZN, et al. Attenuated total reflectance–Fourier transform infrared (ATR-FTIR) spectroscopy analysis for OH, CH and CO functional group in major carrier solvents of raw e-cigarette liquids (PG and VG). AIP Conf Proc. 2022;2022:2454.
69. 10.1039/C7TA02116J10.1039/C7TA02116J ↗
70. 10.1016/j.matpr.2020.03.00510.1016/j.matpr.2020.03.005 ↗
71. 10.1016/j.jddst.2020.10231610.1016/j.jddst.2020.102316 ↗
72. 10.3390/nano1218322610.3390/nano12183226 ↗
73. 10.1038/s41598-024-67579-510.1038/s41598-024-67579-5 ↗
74. 10.3390/jof701006210.3390/jof7010062 ↗
75. 10.1515/gps-2023-008010.1515/gps-2023-0080 ↗
76. 10.1186/s43141-021-00119-010.1186/s43141-021-00119-0 ↗
77. 10.1080/17518253.2023.223238310.1080/17518253.2023.2232383 ↗
78. 10.1016/j.jcis.2020.12.03910.1016/j.jcis.2020.12.039 ↗
79. 10.1515/gps-2023-026710.1515/gps-2023-0267 ↗
80. 10.1080/03601234.2022.214734810.1080/03601234.2022.2147348 ↗
81. 10.1038/s41598-023-43689-410.1038/s41598-023-43689-4 ↗
82. 10.1038/s41598-023-40790-610.1038/s41598-023-40790-6 ↗
83. 10.1111/lam.1341410.1111/lam.13414 ↗
84. 10.1186/s12943-023-01865-010.1186/s12943-023-01865-0 ↗
85. Ioset J-R Brun R Wenzler T et al. Drug screening for kinetoplastids diseases. A training manual for screening in neglected diseases; 2009 DNDi and Pan-Asian Screening Network Geneva Switzerland.
86. 10.1038/s41598-024-52014-610.1038/s41598-024-52014-6 ↗
87. 10.1021/acsomega.2c0394310.1021/acsomega.2c03943 ↗
88. 10.1007/s42250-023-00830-010.1007/s42250-023-00830-0 ↗
89. 10.1016/j.matchemphys.2018.07.01610.1016/j.matchemphys.2018.07.016 ↗
90. 10.1038/s41598-020-79547-w10.1038/s41598-020-79547-w ↗
91. 10.3390/catal1302032110.3390/catal13020321 ↗
92. 10.1186/s12866-023-02975-x10.1186/s12866-023-02975-x ↗
93. 10.1007/s11274-021-03070-x10.1007/s11274-021-03070-x ↗
94. 10.1016/j.nanoso.2024.10124710.1016/j.nanoso.2024.101247 ↗
95. 10.1016/j.molstruc.2023.13682310.1016/j.molstruc.2023.136823 ↗
96. 10.1088/1748-605X/acd03f10.1088/1748-605X/acd03f ↗
97. 10.1007/s10876-019-01570-310.1007/s10876-019-01570-3 ↗
98. 10.3390/antibiotics1309081910.3390/antibiotics13090819 ↗
99. 10.3389/fmicb.2022.102808610.3389/fmicb.2022.1028086 ↗
100. 10.1021/acsami.0c0605410.1021/acsami.0c06054 ↗